The US regulator has cleared Lumakras (sotorasib) in combination with Amgen's anti-EGFR antibody Vectibix (panitumumab) for ...
The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback